Wolverine Asset Management LLC Biogen Inc. Transaction History

Wolverine Asset Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $160,738 - $209,620	-568 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $141,414 - $226,431	546 Added 2481.82%	568 $196,000
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $151,357 - $177,324	-623 Reduced 96.59%	22 $6,000
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $91,905 - $138,340	-389 Reduced 37.62%	645 $157,000
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $204,667 - $236,313	773 Added 296.17%	1,034 $293,000
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $67,510 - $89,405	261 New	261 $69,000
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $119,190 - $186,428	-550 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $557,000 - $705,500	-2,000 Reduced 78.43%	550 $165,000
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $352,212 - $460,596	1,200 Added 88.89%	2,550 $900,000
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $257,519 - $306,910	-1,000 Reduced 42.55%	1,350 $391,000
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $153,820 - $172,290	500 Added 27.03%	2,350 $748,000
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $520,127 - $609,926	1,850	1,850 $579,000

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.